Live data from Hacker News

Blood oxygen monitoring returning to Apple Watch in the US

apple.com

71–80 of 357 posts

Re: Blood oxygen monitoring returning to Apple Watch in the US

#71

Earlier quoted context omitted.

As an employee you shouldn't care, but if you're someone who wants technological progress to continue, you should care whether companies with a slush fund of billions are able to bully those with less money.

You mean like the innovation that someone else here said that was denied a patent in Japan because of prior art? We like software patents now?

I skimmed this and it doesn't look like a software patent to me. It's a giant long description of the hardware.

https://patents.google.com/patent/US10912502B2/

Re: Blood oxygen monitoring returning to Apple Watch in the US

#72

Earlier quoted context omitted.

Good for everyone except whoever had money invested in Masimo

Similar to what HNers are so happy to say about restaurant owners who actually have to be profitable and can’t depend on the largess of investors, if Masimo can’t afford to pay market rates to developers, the company doesn’t deserve to exist.

This, but unironically

Re: Blood oxygen monitoring returning to Apple Watch in the US

#73

Massimo invented this technology (yay Massimo!) in the 90s yet their Japanese patents [1] weren't considered prior art (WTF?) because of technical legal reasons. [1] https://patents.google.com/patent/JP2002542493A5/en%EF%BF%BC So I suppose if Massimo is going to use a technical legality to extend then Apple can use a technical legality to avoid.

Masimo only refined pulse oximetry in the 90s, as pulse oximetry was invented in the 1970s (prior oximeters did not resemble the devices seen today). Everything after that has been tweaks/improvements to the base method, but I wouldn't call them the inventors of the technology.

The only IP that companies can own now are specific methods/improvements, not the base idea of measuring SpO2 with light. All Apple has to do is avoid the specific improvements that Masimo owns and they are fine.

https://en.wikipedia.org/wiki/Pulse_oximetry#History

Re: Blood oxygen monitoring returning to Apple Watch in the US

#74

Earlier quoted context omitted.

In contrast my Garmin and finger pulseox match exactly.

I don't know what Garmin you have, but I'm about half convinced that my Instinct's heart rate measurement is implemented by a PRNG. It's frequently off by 50% from a count/time cross-check. It does not inspire me to move up their range when this watch eventually dies: if they can't get the basic feature working, I have a hard time seeing how they're going to manage anything trickier.

https://www.youtube.com/@TheQuantifiedScientist

That guy is a great reference, and through his videos you can find various measures where he compares devices against reference devices (e.g. the Polar H10 for heart rate for instance). A lot of the reliability of these devices relies upon a tight fit as well.

Re: Blood oxygen monitoring returning to Apple Watch in the US

#76

Earlier quoted context omitted.

25 employees including the CTO, and then bought a building nearby to Masimo's office for them to work in. At least according to the CEO of Masimo in public statements. https://www.youtube.com/watch?v=RR1o8EoW-Eg

Sounds good for the employees, so go Apple?

I think the good is offset by Apple using its other hand to suppress wages for other employees by engaging in “no poaching” practices with other companies.

Probably a net-negative.

Re: Blood oxygen monitoring returning to Apple Watch in the US

#77
post #20

Earlier quoted context omitted.

It's really easy to avoid your employees being "poached": treat them well, and pay them better.

Wow you must work for a company with incredibly deep pockets. No way can massimo compete on salary with apple. Only people in the game who can do that are google facebook apple chatgpt etc.

Masimo was worth ~$16B when this was going down. They are worth $8B today. This is roughly the size of American Airlines. Masimo is not the biggest company, but they are a large publicly-traded company.

The company does $2B in revenue and spends close to $800 million annually in sales, general and admin. This is over 3x their R&D budget. (For reference, Apple's R&D spend is higher than its SG&A spend.)

Per levels.fyi, Masimo is paying senior SDEs in HCOL $150k. They could 10x the comp to these critical employees without it being more than a rounding error in their numbers. (I don't think they would have had to go to 10x. Most people would practically tattoo a brand on themselves for a one-time bonus of $1m.)

Long story short: Masimo does indeed have the money to compete on salary with Apple for this set of employees. They chose to spend the money on attorneys instead.

Some companies don't value engineers. That often works, until they end up in an engineering competition against companies that do value engineers.

Re: Blood oxygen monitoring returning to Apple Watch in the US

#78

Earlier quoted context omitted.

Software patents are a scourge.

I would be a bit more sympathetic if this was not about a trillion dollar company who poached some employees rather than engage in a licensing deal.

I don't how can you patent "read sensor, and process readings on device" I get if how it's actual sensor was patented, not "read and compute"

Re: Blood oxygen monitoring returning to Apple Watch in the US

#79
post #20

Earlier quoted context omitted.

It's really easy to avoid your employees being "poached": treat them well, and pay them better.

Wow you must work for a company with incredibly deep pockets. No way can massimo compete on salary with apple. Only people in the game who can do that are google facebook apple chatgpt etc.

As long as a company is turning a profit, they by definition can afford to be paying their employees better. As a company you can choose not to, but it also means you get to suffer the consequences, and lose the right to complain that your employees were "poached" when in reality it was simply a matter of you not paying them enough to stay.

Re: Blood oxygen monitoring returning to Apple Watch in the US

#80
post #53
post #30

What's the US Customs ruling in question? > This update was enabled by a recent U.S. Customs ruling.

https://rulings.cbp.gov/ruling/H335304 maybe this - from January 2025 It appears the patent is for "User-Worn Device for Noninvasively Measuring a Physiological Parameter of a User". So Apple is simply moving the logic to a non user-worn device - like a phone - to get around the problem. (this is my quick read / conjecture) Here is the original patent https://patents.google.com/patent/US10912502B2/en

Yeah, prob because one cannot patent an algorithm itself, but only a specific implementation. The patent was about a wearable device so i guess the workaround was to do the computations in a non-wearable device.
Post reply on HN